Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...

A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...

Pro-cannabis groups allege with new evidence that the agency has actively shown an "unalterably closed mind" toward marijuana ...

The agency is accused of improperly opposing the rescheduling proposal, conspiring with prohibitionist groups and stacking ...

Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in ...

Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...